HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Investors With $500k+ Losses To Contact The Firm: Application Deadline Approaching

SAN FRANCISCO, CA / ACCESSWIRE / December 31, 2019 / Hagens Berman urges Aurora Cannabis Inc. (NYSE:ACB) investors who have suffered losses in excess of $500,000 to submit their losses now to learn if ... Read More...

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="SAN FRANCISCO, CA / ACCESSWIRE / December 31, 2019 / Hagens Berman urges Aurora Cannabis Inc. (ACB) investors who have suffered losses in excess of $500,000 to submit their losses now to learn if they qualify to recover compensable damages. The January 21, 2020 lead plaintiff deadline in a securities fraud class action that has been filed against the company and senior executives is fast approaching. Hagens Berman is investigating whether the fraudulent period extends beyond that alleged in the complaint.” data-reactid=”11″>SAN FRANCISCO, CA / ACCESSWIRE / December 31, 2019 / Hagens Berman urges Aurora Cannabis Inc. (ACB) investors who have suffered losses in excess of $500,000 to submit their losses now to learn if they qualify to recover compensable damages. The January 21, 2020 lead plaintiff deadline in a securities fraud class action that has been filed against the company and senior executives is fast approaching. Hagens Berman is investigating whether the fraudulent period extends beyond that alleged in the complaint.

Relevant Period: Oct. 23, 2018 – Nov. 14, 2019

Lead Plaintiff Deadline: Jan. 21, 2019

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Sign Up: www.hbsslaw.com/investor-fraud/ACB
Contact An Attorney Now: [email protected]” data-reactid=”14″>Sign Up: www.hbsslaw.com/investor-fraud/ACB
Contact An Attorney Now: [email protected]

844-916-0895

Aurora Cannabis (ACB) Class Action:

The complaint alleges that Defendants misled investors about Aurora Cannabis’ business and prospects.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="More specifically, according to the complaint, Defendants misleadingly and repeatedly touted the Company’s continuing revenue ramp quarter-to-quarter. In addition, as recently as Oct. 3, 2019, the Company provided investors a construction update on its operations and growth initiatives, including on its Aurora Sun and Aurora Nordic 2 projects, touting that Aurora continues to progress construction of the "Sky Class" facilities.” data-reactid=”18″>More specifically, according to the complaint, Defendants misleadingly and repeatedly touted the Company’s continuing revenue ramp quarter-to-quarter. In addition, as recently as Oct. 3, 2019, the Company provided investors a construction update on its operations and growth initiatives, including on its Aurora Sun and Aurora Nordic 2 projects, touting that Aurora continues to progress construction of the “Sky Class” facilities.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="But on Nov. 14, 2019, Aurora Cannabis shocked investors when it announced wider than expected losses and that revenue had declined by 24% quarter over quarter. In addition, the cash-strapped Company disclosed it would be halting construction immediately at its Aurora Nordic 2 and Aurora Sun facilities. ” data-reactid=”19″>But on Nov. 14, 2019, Aurora Cannabis shocked investors when it announced wider than expected losses and that revenue had declined by 24% quarter over quarter. In addition, the cash-strapped Company disclosed it would be halting construction immediately at its Aurora Nordic 2 and Aurora Sun facilities.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="MarketWatch reported, "[a]nalysts said that investors had a reason for anger and distrust." An analyst at Jeffries reportedly noted, "With possible cash pressures evident, announcing ceased construction at facilities despite a press release just 6 weeks ago praising progression, and now EBITDA (and cash) positive looking unlikely this year, it would be fair for investors not to believe them."” data-reactid=”20″>MarketWatch reported, “[a]nalysts said that investors had a reason for anger and distrust.” An analyst at Jeffries reportedly noted, “With possible cash pressures evident, announcing ceased construction at facilities despite a press release just 6 weeks ago praising progression, and now EBITDA (and cash) positive looking unlikely this year, it would be fair for investors not to believe them.”

This news sent the price of Aurora Cannabis shares plummeting about 17% on November 15, 2019, the largest single-day percentage decline for Aurora shares in more than five years and the lowest closing price since October 2017.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Most recently, on Dec. 21, 2019, Defendants announced that Cam Battley stepped down as Chief Corporate Officer effective December 20, 2019. This news sent the price of Aurora Cannabis shares plummeting over 10% on Dec. 23, 2019.” data-reactid=”22″>Most recently, on Dec. 21, 2019, Defendants announced that Cam Battley stepped down as Chief Corporate Officer effective December 20, 2019. This news sent the price of Aurora Cannabis shares plummeting over 10% on Dec. 23, 2019.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="If you purchased shares of Aurora Cannabis and suffered significant losses, click here to discuss your legal rights with Hagens Berman.” data-reactid=”23″>If you purchased shares of Aurora Cannabis and suffered significant losses, click here to discuss your legal rights with Hagens Berman.

“We’re focused on recovering investors’ losses and whether Aurora Cannabis misled investors about its operations and growth initiatives,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Whistleblowers: Persons with non-public information regarding Aurora Cannabis should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].” data-reactid=”25″>Whistleblowers: Persons with non-public information regarding Aurora Cannabis should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.” data-reactid=”26″>About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:

Reed Kathrein, 844-916-0895

SOURCE: Hagens Berman Sobol Shapiro LLP

View source version on accesswire.com:
https://www.accesswire.com/571672/HAGENS-BERMAN-NATIONAL-TRIAL-ATTORNEYS-Urges-Investors-With-500k-Losses-To-Contact-The-Firm-Application-Deadline-Approaching